xylazine   Click here for help

GtoPdb Ligand ID: 523

Synonyms: BAY-VA-1470 | Bayer 1470
Compound class: Synthetic organic
Comment: Xylazine is used by vets as a large animal sedative, often in combination with ketamine. It has sedative, anesthetic, muscle relaxant, and analgesic effects. The marketed formulation contains xylazine hydrochloride (PubChem CID 68554).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 49.69
Molecular weight 220.1
XLogP 2.8
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1cccc(c1NC1=NCCCS1)C
Isomeric SMILES Cc1cccc(c1NC1=NCCCS1)C
InChI InChI=1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14)
InChI Key BPICBUSOMSTKRF-UHFFFAOYSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
α2B-adrenoceptor Hs Agonist Agonist 5.2 – 5.7 pKi - 1-2
pKi 5.2 – 5.7 [1-2]
α2C-adrenoceptor Hs Agonist Agonist 4.8 – 5.9 pKi - 1-2
pKi 4.8 – 5.9 [1-2]
α2A-adrenoceptor Hs Agonist Partial agonist 4.9 – 5.7 pKi - 1-2
pKi 4.9 – 5.7 [1-2]
α2C-adrenoceptor Hs Agonist Agonist 7.1 pEC50 - 2
pEC50 7.1 [2]
Description: ERK1/2 phosphorylation
α2B-adrenoceptor Hs Agonist Agonist 6.4 – 7.4 pEC50 - 2
pEC50 7.4 [2]
Description: ERK1/2 phosphorylation
pEC50 6.4 [2]
Description: cAMP generation
α2A-adrenoceptor Hs Agonist Agonist 5.1 – 7.5 pEC50 - 1-2
pEC50 7.5 [2]
Description: increased ERK1/2 phosphorylation
pEC50 5.7 [1]
Description: GTPγs binding
pEC50 5.1 [2]
Description: increased cAMP generation
α2B-adrenoceptor Hs Agonist Agonist 7.7 pIC50 - 2
pIC50 7.7 [2]
Description: inhibition of forskolin stimulated cAMP generation
α2C-adrenoceptor Hs Agonist Agonist 6.8 pIC50 - 2
pIC50 6.8 [2]
Description: inhibition of cAMP production
α2A-adrenoceptor Hs Agonist Agonist 6.5 pIC50 - 2
pIC50 6.5 [2]
Description: inhibition of forskolin stimulated cAMP generation
Ligand mentioned in the following text fields